Updated Jul 16, 2026
Aslan Fred has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $488K.

Fred Aslan is the President and CEO of Artiva Biotherapeutics, Inc., a biopharmaceutical company focused on developing NK cell therapies for cancer treatment. He has held this position since the company's inception and has been involved in various aspects of its operations and strategic direction.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-20 | ARTV | Artiva Biotherapeutics, Inc. | S — Open-market sale | 27.1K | $9.01 | $244K |
| 2026-02-18 | ARTV | Artiva Biotherapeutics, Inc. | F — Tax withholding / forfeiture | 14.6K | $4.00 | $58K |
| 2026-02-18 | ARTV | Artiva Biotherapeutics, Inc. | A — Grant or award | 366.9K | $0.00 | |
| 2025-12-13 | ARTV | Artiva Biotherapeutics, Inc. | A — Grant or award | 869.1K | $0.00 | |
| 2025-11-18 | ARTV | Artiva Biotherapeutics, Inc. | S — Open-market sale | 6.4K | $3.38 | $22K |
| 2025-11-18 | ARTV | Artiva Biotherapeutics, Inc. | F — Tax withholding / forfeiture | 6.3K | $3.25 | $21K |
| 2025-10-17 | ARTV | Artiva Biotherapeutics, Inc. | S — Open-market sale | 25.5K | $6.00 | $153K |
| 2025-05-15 | ARTV | Artiva Biotherapeutics, Inc. | F — Tax withholding / forfeiture | 4.5K | $2.75 | $12K |
| 2025-05-15 | ARTV | Artiva Biotherapeutics, Inc. | S — Open-market sale | 25.5K | $2.73 | $70K |
| 2025-05-15 | ARTV | Artiva Biotherapeutics, Inc. | F — Tax withholding / forfeiture | 4.5K | $2.13 | $10K |
Fred Aslan is the President and CEO of Artiva Biotherapeutics, Inc., a biopharmaceutical company focused on developing NK cell therapies for cancer treatment. He has held this position since the company's inception and has been involved in various aspects of its operations and strategic direction.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($488K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Aslan Fred profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.